Spontaneous regression of metastatic cancer: Learning from neuroblastoma

Nature Reviews Cancer

Volumn 14, Issue 2, 2014, Pages 71-72

  Diede, Scott J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; ANIMALS; HUMANS; INFANT; NEOPLASM METASTASIS; NEUROBLASTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84894518940     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3656     Document Type: Review

References (7)

1. Cheung, N.-K. V. & Dyer, M. A. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature Rev. Cancer 13, 397-411 (2013).
2. Cohn, S. L. et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J. Clin. Oncol. 27, 289-297 (2009).
3. Pugh, T. J. et al. The genetic landscape of high-risk neuroblastoma. Nature Genet. 45, 279-284 (2013).
4. Molenaar, J. J. et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589-593 (2012).
5. Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nature Genet. 45, 12-17 (2013).
6. Nakagawara, A. et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328, 847-854 (1993).
7. D'Angio, G. J., Evans, A. E. & Koop, C. E. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1, 1046-1049 (1971).